Swiss TPH has a long-standing expertise in biomarker research. It has set up state-of-the art bio-banking infrastructure to support human biomonitoring and exposome research. Human biomonitoring measures specific chemicals and molecules in accessible biomaterials such as blood or urine for improved and integrated measurement of exposure to chemicals in the environment, nutrition or other consumables. Exposome research can be viewed as an extension of human biomonitoring by applying personalised health technology (e.g. (environmental) sensoring technology; -omics technology) towards a better understanding of causal health risks and mechanisms.
Biomarkers and personalised health and medicine approaches form the basis of studies towards the identification of novel diagnostics and therapies and the refined characterisation of diseases and their infectious causes. Swiss TPH takes part in important local, national, and international personalised health and biobanking initiatives.